MBNL1 drives dynamic transitions between fibroblasts and myofibroblasts in cardiac wound healing

Cell Stem Cell. 2022 Mar 3;29(3):419-433.e10. doi: 10.1016/j.stem.2022.01.012. Epub 2022 Feb 16.

Abstract

Dynamic fibroblast to myofibroblast state transitions underlie the heart's fibrotic response. Because transcriptome maturation by muscleblind-like 1 (MBNL1) promotes differentiated cell states, this study investigated whether tactical control of MBNL1 activity could alter myofibroblast activity and fibrotic outcomes. In healthy mice, cardiac fibroblast-specific overexpression of MBNL1 transitioned the fibroblast transcriptome to that of a myofibroblast and after injury promoted myocyte remodeling and scar maturation. Both fibroblast- and myofibroblast-specific loss of MBNL1 limited scar production and stabilization, which was ascribed to negligible myofibroblast activity. The combination of MBNL1 deletion and injury caused quiescent fibroblasts to expand and adopt features of cardiac mesenchymal stem cells, whereas transgenic MBNL1 expression blocked fibroblast proliferation and drove the population into a mature myofibroblast state. These data suggest MBNL1 is a post-transcriptional switch, controlling fibroblast state plasticity during cardiac wound healing.

Keywords: RNA binding proteins; cardiac remodeling; fibroblast; fibroblast heterogeneity; fibrosis; myofibroblast; wound healing.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Cell Differentiation
  • Cicatrix* / pathology
  • DNA-Binding Proteins* / metabolism
  • Fibroblasts / metabolism
  • Fibrosis
  • Mice
  • Myofibroblasts* / metabolism
  • RNA-Binding Proteins* / metabolism

Substances

  • DNA-Binding Proteins
  • Mbnl1 protein, mouse
  • RNA-Binding Proteins